The company
Krystal Biotech, Inc.
KRYS · Nasdaq
KRYS stood above a rising 150-day average in 51 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 0.3% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Just dropped out
- Weeks in an uptrend
- out for 1
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $188.5M
- Officials’ trades on record
- 4
- Institutions holding
- 391 (+49)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 51 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
4 disclosed lines: House 1, Senate 0, executive 3; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $100k–$250k | 24 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 15 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 15 May 2026filed 1 Jul 2026 |
| Chris Jacobs House: U.S. House ClerkNY27 | bought | $1k–$15k | 12 Dec 2022filed 20 Jan 2023 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Krish S. KrishnanPresident and CEO | sold | 520at $354.54 | 4 Sep 2026filed 4 Sep 2026 |
| Krish S. KrishnanPresident and CEO | sold | 2,029at $355.57 | 4 Sep 2026filed 4 Sep 2026 |
| Krish S. KrishnanPresident and CEO | sold | 3,297at $356.37 | 4 Sep 2026filed 4 Sep 2026 |
| Krish S. KrishnanPresident and CEO | sold | 3,981at $357.57 | 4 Sep 2026filed 4 Sep 2026 |
| Krish S. KrishnanPresident and CEO | sold | 3,143at $358.42 | 4 Sep 2026filed 4 Sep 2026 |
| Krish S. KrishnanPresident and CEO | sold | 3,357at $359.39 | 4 Sep 2026filed 4 Sep 2026 |
| Krish S. KrishnanPresident and CEO | sold | 2,266at $360.46 | 4 Sep 2026filed 4 Sep 2026 |
| Krish S. KrishnanPresident and CEO | sold | 1,214at $361.61 | 4 Sep 2026filed 4 Sep 2026 |
| Krish S. KrishnanPresident and CEO | sold | 2,010at $362.65 | 4 Sep 2026filed 4 Sep 2026 |
| Krish S. KrishnanPresident and CEO | sold | 573at $363.34 | 4 Sep 2026filed 4 Sep 2026 |
| Krish S. KrishnanPresident and CEO | sold | 1,358at $364.48 | 4 Sep 2026filed 4 Sep 2026 |
| Krish S. KrishnanPresident and CEO | sold | 847at $365.42 | 4 Sep 2026filed 4 Sep 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| FMR LLCadded · filed 13 Aug 2026 | 4,418,197$1.6B | +44,210+1.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 4,181,432$1.6B | +240,976+6.1% |
| Avoro Capital Advisors LLCunchanged · filed 14 Aug 2026 | 2,888,888$1.1B | 00.0% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 1,574,905$585.3M | +118,178+8.1% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 1,351,158$502.2M | +36,724+2.8% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 1,240,567$461.1M | +75,243+6.5% |
| Soleus Capital Management, L.P.reduced · filed 11 Aug 2026 | 939,254$349.1M | -213,833−18.5% |
| Capital World Investorsreduced · filed 12 Aug 2026 | 777,843$289.1M | -46,877−5.7% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 698,993$259.8M | +55,018+8.5% |
| Hood River Capital Management LLCadded · filed 14 Aug 2026 | 663,375$246.6M | +43,789+7.1% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.